Company Profile

Angulus Corporation
Profile last edited on: 11/17/2017      CAGE: 79H67      UEI: X174N3RSTX13

Business Identifier: Device to reduce incidence of ventilator associated pneumonia (VAP)
Year Founded
2014
First Award
2016
Latest Award
2016
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

17 East 17th Street 4th Floor
New York, NY 10003
   N/A
   N/A
   www.angulus.us
Location: Single
Congr. District: 12
County: New York

Public Profile

Founded by an interdisciplinary team of clinicians, engineers, and business operators Angulus is organized around addressing discrete unmet needs with simple, elegant solutions. The company’s initial focus has been to address the problem of Ventilator Associated Pneumonia (VAP) and other hospital acquired conditions by improving provider behavior and compliance with patient elevation guidelines. Ventilator-Associated Pneumonia is a cause of morbidity and mortality across ICU units. Guidelines recommend that ventilated patients be positioned at 30 to 45 degrees in order to reduce the risk of VAP, but compliance among providers remains poor. Furthermore, patients often slide down hospital beds, mitigating the benefit of head of bed angle compliance. Based on IP owned by the company, Angulus is the only device that attaches to the patient’s chest wall, evaluates real-time patient angle, and integrates with existing ICU systems to signal providers when patients slide outside of the desired recumbency.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Key People / Management

  Frank Glaser -- CEO and Founder

  Elizabeth Cordell -- Director of Clinical Trials

  Viktor Gamarnik -- CTO

  Quang Nguyen -- COO

Company News

There are no news available.